| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MIMEDX GROUP, INC. | Chief Executive Officer | Common Stock | 100K | $716K | $7.16 | Jun 23, 2023 | Direct |
| Anika Therapeutics, Inc. | Director | Common Stock | 6.24K | $161K | $25.79 | Jul 9, 2024 | Direct |
| Neuronetics, Inc. | Director | Common Stock | 43.1K | $136K | $3.16 | May 25, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ANIK | Anika Therapeutics, Inc. | Jul 9, 2024 | 1 | $0 | 4 | Jul 11, 2024 | Director |
| ANIK | Anika Therapeutics, Inc. | Jun 3, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Director |
| ANIK | Anika Therapeutics, Inc. | May 28, 2024 | 0 | $0 | 3 | Jun 5, 2024 | Director |
| MDXG | MIMEDX GROUP, INC. | Jun 22, 2023 | 2 | $640K | 4 | Jun 26, 2023 | Chief Executive Officer |
| STIM | Neuronetics, Inc. | May 25, 2023 | 1 | $0 | 4 | May 30, 2023 | Director |
| MDXG | MIMEDX GROUP, INC. | Jan 27, 2023 | 1 | $0 | 4 | Jan 31, 2023 | Chief Executive Officer |
| MDXG | MIMEDX GROUP, INC. | Jan 27, 2023 | 0 | $0 | 3 | Jan 31, 2023 | Chief Executive Officer |
| STIM | Neuronetics, Inc. | Jan 1, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Director |
| STIM | Neuronetics, Inc. | Jan 1, 2023 | 0 | $0 | 3 | Jan 4, 2023 | Director |